Cargando…
Identification of Conserved Epitopes in SARS-CoV-2 Spike and Nucleocapsid Protein
BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel virus that first occurred in Wuhan in December 2019. The spike glycoproteins and nucleocapsid proteins are the most common targets for the development of vaccines and antiviral drugs. OBJECTIVE: We herein analyze the...
Autores principales: | Forcelloni, Sergio, Benedetti, Anna, Dilucca, Maddalena, Giansanti, Andrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8905637/ https://www.ncbi.nlm.nih.gov/pubmed/35386436 http://dx.doi.org/10.2174/1389202923666211216162605 |
Ejemplares similares
-
Codon Usage and Phenotypic Divergences of SARS-CoV-2 Genes
por: Dilucca, Maddalena, et al.
Publicado: (2020) -
Identification of SARS-CoV-2 Nucleocapsid and Spike T-Cell Epitopes for Assessing T-Cell Immunity
por: Lee, Eunok, et al.
Publicado: (2021) -
The Epitope Study on the SARS-CoV Nucleocapsid Protein
por: Li, Shuting, et al.
Publicado: (2003) -
Bioinformatics prediction of B and T cell epitopes within the spike and nucleocapsid proteins of SARS-CoV2
por: Dawood, Reham M., et al.
Publicado: (2021) -
Identification of B-Cell Linear Epitopes in the Nucleocapsid (N) Protein B-Cell Linear Epitopes Conserved among the Main SARS-CoV-2 Variants
por: Rodrigues-da-Silva, Rodrigo N., et al.
Publicado: (2023)